References

About human parainfluenza viruses (HPIVs). (2024). Centers for Disease Control and Prevention. https://www.cdc.gov/parainfluenza/about/index.html

Baluch, A., Rajnik, M., & Maranich, A. (2017). Human metapneumovirus: Practice essentials, background, pathophysiology. Medscape. https://emedicine.medscape.com/article/237691-overview

Branche, A., & Falsey, A. (2016). Parainfluenza virus infection. Seminars in Respiratory and Critical Care Medicine, 37(4):538-554. doi:10.1055/s-0036-1584798.

Brochot, A., Guilbot, A., Haddioui, L., & Roques, C. (2017). Antibacterial, antifungal, and antiviral effects of three essential oil blends. Microbiologyopen, 6(4):e00459. doi:10.1002/mbo3.459.

Carvajal, J., Avellaneda, A., Salazar-Ardiles, C., Maya, J., Kalergis, A., & Lay, M. (2019). Host components contributing to respiratory syncytial virus pathogenesis. Frontiers in Immunology. doi:10.3389/fimmu.2019.02152.

COVID data tracker. (2025). Centers for Disease Control and Prevention. https://covid.cdc.gov/covid-data-tracker

Davidson, M. (2025). Molecular expressions cell biology: The influenza (FLU) virus. https://micro.magnet.fsu.edu/cells/viruses/influenzavirus.html

Dias, A., Bouvier, D., Crepin, T., et al. (2009). The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit. Nature, 458(7240):914-918. doi:10.1038/nature07745.

Dutt, J., Ganatra, B., Suthar, N, et al. (2021). A randomized and comparative study to assess safety and efficacy of supplemental treatment of a herbal formulation: Aayudh advance comprising essential oils in patients with coronavirus 2019 (COVID-19). Contemporary Clinical Trials Communications. doi:10.1016/j.conctc.2021.100755

Ghaffari, H., Tavakoli, A., Moradi, A., et al. (2019). Inhibition of H1N1 influenza virus infection by zinc oxide nanoparticles: another emerging application of nanomedicine. Journal of Biomedical Science, 26(1):70. doi:10.1186/s12929-019-0563-4.

Grant, W., & Giovannucci, E. (2009). The possible roles of solar ultraviolet-B radiation and vitamin D in reducing case-fatality rates from the 1918–1919 influenza pandemic in the United States. Dermato Endocrinology, 1(4):215-219. doi: 10.4161/derm.1.4.9063

Hays, C. (2008). The respiratory viruses Influenza, RSV, and Rhinoviruses. http://www.columbia.edu/itc/hs/medical/pathophys/id/2008/respiratoryvirusesNotes.pdf

How the flu virus can change: “Drift” and “shift”. (2024). Centers for Disease Control and Prevention. https://www.cdc.gov/flu/php/viruses/change.html

Hunt, M. (2016). Parainfluenza-respiratory syncytial-adenovirus. Microbiology and Immunology On-line. http://www.microbiologybook.org/virol/para-rsv-aden-ver2.htm

Ison, M., Lee, N., & Cohen, J. (2017). Noninfluenza respiratory viruses. Infectious Diseases. Elsevier.

Kauvar, L., Harcourt, J., Haynes, L., & Tripp, R. (2010). Therapeutic targeting of respiratory syncytial virus G-protein. Immunotherapy, 2(5):655-661. doi:10.2217/imt.10.5311.

Kubala, J. (2019). 15 impressive herbs with antiviral activity. Healthline. https://www.healthline.com/nutrition/antiviral-herbs

McCarty, M., & DiNicolantonio, J. (2020). Nutraceuticals have potential for boosting the type 1 interferon response to RNA viruses including influenza and coronavirus. Progress in Cardiovascular Diseases, 63(2020):383-385. doi: 10.1016/j.pcad.2020.02.007

Miguez-Rey, E., Choi, D., Kim, S., Yoon, S., & Sandulescu, O. (2022). Monoclonal antibody therapies in the management of SARS-CoV-2 infection. Expert opinion on investigational drugs, 31(1), 41–58. https://doi.org/10.1080/13543784.2022.2030310

Neethu, R., Janardhan, D., Reddy, M., Batra, S., Srivastava, S., & Syal, K. (2022). Vitamin C and its therapeutic potential in the management of COVID-19. Clinical Nutrition European Society for Clinical Nutrition and Metabolism, 50:8-14.doi: 10.1016/j.clnesp.2022.05.026

Newton, A., Cardani, A., & Braciale T. (2016). The host immune response in respiratory virus infection: balancing virus clearance and immunopathology. Seminars in Immunopathology, 38(4):471-482. doi:10.1007/s00281-016-0558-0.

Respiratory syncytial virus infection (RSV). (2024). Centers for Disease Control and Prevention. https://www.cdc.gov/rsv/index.html

Sharland, M. (2016). Influenza and parainfluenza. Manual of Childhood Infections: The Blue Book. Oxford Press.

Stockton, J., Stephenson, I., Fleming, D., & Zambon, M. (2002). Human metapneumovirusas a cause of community-acquired respiratory illness. Emerging Infectious Diseases, 8(9):897-901. doi:10.3201/eid0809.020084.

Togan, C. (2016). Structure of rhinovirus C revealed. National Institutes of Health. https://www.nih.gov/news-events/nih-research-matters/structure-rhinovirus-c-revealed

Treatment for Highest-Risk RSV patients. (n.d.). SYNAGIS®. https://www.synagishcp.com/

Tseliou, M., Pirintsos, S., Lionis, C., Castanas, E., & Sourvinos, G. (2019). Antiviral effect of an essential oil combination derived from three aromatic plants (Coridothymus capitatus (L.) Rchb. f., Origanum dictamnus L. and Salvia fruticosa Mill.) against viruses causing infections of the upper respiratory tract. Journal of Herbal Medicine, 17-18(1):100288. doi:10.1016/j.hermed.2019.100288.

Usachey, E., Pyankov, O., Usacheva, O., & Agranovski, I. (2013). Antiviral activity of tea tree and eucalyptus oil aerosol and vapor. Journal of Aerosol Science, 59:22-30. doi:10.1016/j.jaerosci.2013.01.004.

Vimalanathan, S., & Hudson, J. (2014). Anti-influenza virus activity of essential oils and vapors. Essential Oil International Journal, 2(1):47-53. https://www.essencejournal.com/vol2/issue1/pdf/8.1.pdf

Wu, S., Patel, K., Booth, L., Metcalf, J., Lin, H., & Wu, W. (2010). Protective essential oil attenuates influenza virus infection: An in vitro study in MDCK cells. BMC Complementary and Alternative Medicine, 10(1):69. doi:10.1186/1472-6882-10-69.

Zhang, Y., Xu, Z., Cao, Y. (2020). Host–virus interaction: How host cells defend against influenza A virus infection. Viruses, 12(4):376. doi:10.3390/v12040376.